Prostate Cancer Clinical Trials in Los Angeles

Showing 141-160 of 325 trials

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

NCT05131815

The purpose of this prospective, interventional, single-arm pilot study is to evaluate whether virtually delivered group-based physical activity is feasible for adolescent and young adult (AYA) cancer survivors. AYAs who were diagnosed with cancer and have completed cancer treatment will be recruited for this study. This study will enroll 20 participants in total and will last approximately 3 months.

CancerCancer MetastaticNeoplasms+19 more

Cedars-Sinai Medical Center8 participantsStarted Jul 2022

Los Angeles, California, United States

Active Not RecruitingNA< 1 mile

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

NCT02176902

This randomized phase II trial will evaluate if a low omega-6, high omega-3 fat diet combined with fish oil has the potential to delay disease progression in patients with prostate cancer undergoing active surveillance.

Adenocarcinoma of the ProstateStage I Prostate CancerStage IIA Prostate Cancer+1 more

Jonsson Comprehensive Cancer Center107 participantsStarted Nov 2014

Los Angeles, California, United States

Active Not RecruitingPhase 2< 1 mile

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

NCT05032040

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in patients with selected advanced gynecologic and genitourinary malignancies.

Ovarian CancerClear Cell CarcinomaEndometrial Cancer+2 more

Xencor, Inc.170 participantsStarted Jul 2022

Prescott, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +14 more locations

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Prostate Cancer Trials in Other Cities

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Other Conditions in Los Angeles